-
FDA primes industry for GDUFA II fee structure changes
In the nearly five years since the Generic Drug User Fee Agreement was enacted under the Food and Drug Administration Safety and Innovation Act of 2012, through the FDA’s Office of Generic Drug, GDUFA has generated some $1.5 billion in user fees and has seen 1,992 approvals issued.
(To view the full Category Review, click here.)
-
Diabetic consumers spend 35% more on OTC products
Today’s diabetes patients represent a coveted consumer base for retail pharmacy no matter how you characterize that diabetes spend. For example, consumers with diabetes spend 35% more on OTC products than the average consumer, noted Jeff Gregori, group VP consumer and shopper analytics for Nielsen, during a presentation at the 2016 National Association of Chain Drug Stores Total Store Expo.